What's breaking now, across thousands of outlets.
Plus news about Altis Labs, Matisse Pharmaceuticals, AstraZeneca, Novo, Longeveron, Connexus Therapeutics and Avacta. A new Parkinson’s biotech: The Michael J. Fox Foundation is supporting a non-hallucinogenic psychedelic at Ariadne Bio, a biotech that
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Nora LeTorre, the CEO of Eat Real, joins "CBS Mornings" to share some tips for making your child's school lunches healthier.
Nearly half of Americans with medical debt owe at least $2,000, forcing them to make tough choices, new research shows.
Congress just held its first menopause hearing. Behind the milestone is a striking reality—medicine is still catching up to women.
The reverse merger party is still buzzing. This time, it's a cardio and endocrine startup with two drugs in Phase 2 and a biotech working on a long-acting immunology and inflammation (I&I) drug.
As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount Sinai have published two large-scale studies showing that wildfire smoke may pose…
Tuberculosis (TB) remains one of the world's leading causes of death, and preventing post-treatment relapse continues to be a major global health challenge.
